期刊文献+

HIF-1α、VEGF的表达及微血管密度与乳腺癌生物学行为的关系 被引量:5

The Expression of Hypoxia-Inducible Factor-1α,VEGE and MVD and Their Relationship with the Biological Behavior in Breast Cancer
下载PDF
导出
摘要 目的检测缺氧诱导因子_1α(HIF_1α)及VEGF、CD34在乳腺癌的表达,探讨其与缺氧情况下乳腺癌血管生成及其与生物学行为的关系。方法采用免疫组织化学S_P法检测68例乳腺癌组织中HIF_1α及VEGF的表达,并用CD34抗体标记血管内皮细胞,计数乳腺癌组织中MVD。结果68例乳腺癌标本中有37例(54%)表达HIF_1α;HIF_1α表达组VEGF及CD34表达强度均高于HIF_1α阴性表达组;HIF_1α表达与肿瘤的分化程度及淋巴结转移密切相关(P<0.01)。HIF_1α表达与VEGF、CD34表达之间存在显著相关性。结论HIF_1α在乳腺癌组织中存在着过表达,部分的参与了乳腺癌的演进;HIF_1α通过调节VEGF的表达,在乳腺癌血管生成中发挥重要作用;HIF_1α、VEGF的过表达及高微血管密度(MVD)与乳腺癌的不良发展有关,可能成为预测乳腺癌侵袭、转移及预后的重要指标。 Objective To detect the expression of hypoxia-inducible factor-1α,VEGF and CD34 in breast cancer and discuss the relation between the angiogenesis in breast cancer and in biological action in case of anoxia.Methods We examined sixty_eight breast cancer specimen by adopting S_P immunohistochemical.We mark the cell in endothelium of blood vessel with CD34 antibody and count the MVD in the tissue of breast cancer.Results Thirty_seven cases in the sixty_eight breast cancer specimen express HIF_1α,The expression intensity of VEGF and CD34 in the positive expression group is higher than the negative expression group.It is closely related to the differentiation degree of tumor and metastasis of lymph node ( P <0 01).The expression of HIF_1α has a direct bearing on the expression of VEGF and CD34.Conclusions HIF_1α in breast cancer's tissue exists overexpression. It partially participates in the evolvement and development of breast cancer. HIF_1α plays an important role in the building of breast cancer's blood vessel by regulating the expression of VEGF.The overexpressions of HIF-1α and VEGF and MVD have relation with the ill development of breast cancer. It can be an important index for forecasting breast cancer's invasion, metastasis and prognosis.
出处 《河南肿瘤学杂志》 2005年第3期158-160,共3页 Henan Journal of Oncology
关键词 乳腺癌 缺氧诱导因子-1Α 血管内皮生长因子 微血管密度 CD34 免疫组织化学 breast cancer hypoxia-inducible factor 1α vascular endothelial growth factor microvessel density CD34 immunohistochemistry
  • 相关文献

参考文献9

  • 1Sutherland RM. Tumor hypoxia and gene expression[ J]. Acta Oncol, 1998,37(3) :567.
  • 2Zhong H, De Marzo AM, Lauguner E, et al. Overexpression of hypoxia-inducible factor lalpha in common human cancers and their metastases[J].Cancer Res, 1999,59(22) :5830 - 5835.
  • 3Blagosklonny MV, An WG, Romanova LY, et al. P53 inhibits hypoxia-inducible factor-stimulated transcription[ J]. J Biol Chem , 1998,273 (20):11995 - 11998.
  • 4Kinoshita J, kitamura K. Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer[ J]. Breast Cancer Res Treat, 2001,66(2): 159 - 164.
  • 5Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma [J] .J Natl Cancer Inst, 1992,84(24) :1875 - 1887.
  • 6Hon WC,Wilson MI, Harlos K, et al. Structural basis for the recognition of hydroxyproline in HIF- alpha by pVHL[ J ]. Nature, 2002,417 ( 6892 ): 975-978.
  • 7Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor [ J ]. J Cell Sci, 1995,108 (Pt6) :2369 - 2379.
  • 8Shweiki D, Itrin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-mediated angiogenesis[J]. Nature,1992,359(6398 ): 843 - 845.
  • 9Liu LX, Lu H, Luo Y, et al. Stablization of vascular endothelial growth factor mRNA by hypoxia-inducible factorl [J]. Biochem Biophys Res Commun,2002,291 (4) :908 - 914.

同被引文献35

  • 1李贻奎,宁可永,梁嵘,李连达.大鼠冠状动脉结扎心肌缺血模型方法的改进[J].中国新药杂志,2005,14(4):427-428. 被引量:51
  • 2王培利,雷燕,林燕林,陈可冀.当归补血汤含药血清对培养内皮细胞生长因子受体表达的影响[J].中西医结合心脑血管病杂志,2006,4(3):209-212. 被引量:24
  • 3徐叔云,卞如濂,陈修主编.药理实验方法学第3版.北京:人民卫生出版社,2005:1757-1768
  • 4王钟秀,杨林花.HIF-1、VEGF与缺血性脑血管病[J].血栓与止血学,2007,13(4):189-192. 被引量:1
  • 5Gille H,Kowalski J,Li B,LeCouter J,Moffat B,Zioncheck TF,Pelletier N,Ferrara N.Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2).A reassessment using novel receptor-specific vascular endothelial growth factor mutants.J Biol Chem.2001; 276(5):3222-3230.
  • 6Gerber HP,McMurtrey A,Kowalski J,Yan M,Keyt BA,Dixit V,Ferrara N.Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway.Requirement for Flk-1/KDR activation.J Biol Chem.1998; 273(46):30336-30343.
  • 7Zeng H,Sanyal S,Mukhopadhyay D.Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation,respectively.J Biol Chem.2001; 276(35):32714-32719.
  • 8Asahara T,Murohara T,Sullivan A,Silver M,van der Zee R,Li T,Witzenbichler B,Schatteman G,Isner JM.Isolation of putative progenitor endothelial cells for angiogenesis.Science.1997; 275(5302):964-967.
  • 9Schaper W,Ito WD.Molecular mechanisms of coronary collateral vessel growth.Circ Res.1996; 79(5):911-919.
  • 10Ng YS,Krilleke D,Shima DT.VEGF function in vascular pathogenesis.Exp Cell Res.2006; 312(5):527-537.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部